Last update 07 Jan 2026

Autologous Adipose-derived Mesenchymal Stromal Cells(Mayo Clinic)

Overview

Basic Info

Drug Type
Mesenchymal stem cell therapy
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System DiseasesOther DiseasesCardiovascular Diseases+ [1]
Active Indication
ParalysisSpinal Cord InjuriesTraumatic spinal cord injury+ [1]
Inactive Indication-
Originator Organization
Mayo ClinicMayo Clinic
Active Organization
Mayo ClinicMayo Clinic
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

10
Clinical Trials associated with Autologous Adipose-derived Mesenchymal Stromal Cells(Mayo Clinic)
NCT04312113
/ Active, not recruitingPhase 1IIT
A Phase I Single Site Open Label Study of Intra-arterial Delivery of Mesenchymal Stem Cells for Luminal Ulcerative Colitis
NCT04520373
/ Active, not recruitingPhase 2IIT
CELLTOP Part II: A Phase II Clinical Trial of Autologous Adipose Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury
NCT03840343
/ TerminatedPhase 1IIT
Intra-arterially Delivered Autologous Mesenchymal Stem/Stromal Cell Therapy in Patients With Diabetic Kidney Disease: A Phase I Study
100 Clinical Results associated with Autologous Adipose-derived Mesenchymal Stromal Cells(Mayo Clinic)
Login to view more data
100 Translational Medicine associated with Autologous Adipose-derived Mesenchymal Stromal Cells(Mayo Clinic)
Login to view more data
100 Patents (Medical) associated with Autologous Adipose-derived Mesenchymal Stromal Cells(Mayo Clinic)
Login to view more data
100 Deals associated with Autologous Adipose-derived Mesenchymal Stromal Cells(Mayo Clinic)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ParalysisPhase 2
United States
Mayo ClinicMayo Clinic
25 Jun 2020
Spinal Cord InjuriesPhase 2
United States
Mayo ClinicMayo Clinic
25 Jun 2020
Traumatic spinal cord injuryPhase 2
United States
Mayo ClinicMayo Clinic
25 Jun 2020
Arteriovenous FistulaPhase 1
United States
Mayo ClinicMayo Clinic
07 Jun 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free